![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1550037 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of ICMT mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1550037 | 6480464 | Ethinyl Estradiol affects the expression of ICMT mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1550037 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ICMT mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1550037 | 6480464 | Ethinyl Estradiol results in increased expression of ICMT mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550037 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ICMT mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ICMT mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1603405 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ICMT mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1550037 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ICMT mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1603405 | 6480464 | Lactic Acid results in decreased expression of ICMT mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | ISO | RGD:1603405 | 6480464 | beta-methylcholine affects the expression of ICMT mRNA | CTD | PMID:21179406 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ICMT mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | ISO | RGD:1603405 | 6480464 | Aflatoxin B1 results in increased expression of ICMT mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ICMT mRNA | CTD | PMID:33354967 | aflatoxin B1 | increases methylation | ISO | RGD:1603405 | 6480464 | Aflatoxin B1 results in increased methylation of ICMT 3' UTR, Aflatoxin B1 results in increased methylation of ICMT gene | CTD | PMID:27153756, PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:1603405 | 6480464 | Tretinoin results in decreased expression of ICMT mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ICMT mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | ISO | RGD:1603405 | 6480464 | aristolochic acid I results in increased expression of ICMT mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases methylation | ISO | RGD:1603405 | 6480464 | Benzo(a)pyrene results in increased methylation of ICMT promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ICMT mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | RGD:1603405 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ICMT gene | CTD | PMID:31601247 | bisphenol A | decreases methylation | ISO | RGD:1550037 | 6480464 | bisphenol A results in decreased methylation of ICMT promoter | CTD | PMID:27312807 | CGP 52608 | multiple interactions | ISO | RGD:1603405 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ICMT gene] | CTD | PMID:28238834 | cobalt dichloride | decreases expression | ISO | RGD:1603405 | 6480464 | cobaltous chloride results in decreased expression of ICMT mRNA | CTD | PMID:19320972 | copper atom | multiple interactions | ISO | RGD:1603405 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ICMT mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1603405 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ICMT mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | RGD:1603405 | 6480464 | Copper Sulfate results in increased expression of ICMT mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | RGD:1603405 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RGD:1603405 | 6480464 | Cyclosporine results in decreased expression of ICMT mRNA | CTD | PMID:20106945, PMID:25562108 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ICMT mRNA | CTD | PMID:17379624 | dioxygen | decreases expression | ISO | RGD:1603405 | 6480464 | Oxygen deficiency results in decreased expression of ICMT mRNA | CTD | PMID:26516004 | Enterolactone | multiple interactions | ISO | RGD:1603405 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA | CTD | PMID:19167446 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ICMT mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | RGD:1550037 | 6480464 | Folic Acid results in decreased expression of ICMT mRNA | CTD | PMID:25629700 | folic acid | decreases expression | ISO | RGD:1603405 | 6480464 | Folic Acid results in decreased expression of ICMT mRNA | CTD | PMID:21867686 | fulvestrant | multiple interactions | ISO | RGD:1603405 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ICMT gene | CTD | PMID:31601247 | hydralazine | multiple interactions | ISO | RGD:1603405 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ICMT mRNA | CTD | PMID:17183730 | hydrogen cyanide | decreases expression | ISO | RGD:1550037 | 6480464 | Hydrogen Cyanide results in decreased expression of ICMT mRNA | CTD | PMID:33914522 | lead(0) | affects expression | ISO | RGD:1603405 | 6480464 | Lead affects the expression of ICMT mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:1603405 | 6480464 | Lead affects the expression of ICMT mRNA | CTD | PMID:28903495 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ICMT mRNA | CTD | PMID:24136188 | mitomycin C | affects response to substance | ISO | RGD:1603405 | 6480464 | ICMT protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 | paracetamol | affects expression | ISO | RGD:1550037 | 6480464 | Acetaminophen affects the expression of ICMT mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ICMT mRNA | CTD | PMID:33387578 | pirinixic acid | increases expression | ISO | RGD:1550037 | 6480464 | pirinixic acid results in increased expression of ICMT mRNA | CTD | PMID:18301758 | potassium cyanide | decreases expression | ISO | RGD:1550037 | 6480464 | Potassium Cyanide results in decreased expression of ICMT mRNA | CTD | PMID:33914522 | progesterone | affects expression | ISO | RGD:1550037 | 6480464 | Progesterone affects the expression of ICMT mRNA | CTD | PMID:17251523 | rac-lactic acid | decreases expression | ISO | RGD:1603405 | 6480464 | Lactic Acid results in decreased expression of ICMT mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | RGD:1603405 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ICMT mRNA | CTD | PMID:23557933 | Salinomycin | decreases expression | ISO | RGD:1603405 | 6480464 | salinomycin results in decreased expression of ICMT mRNA | CTD | PMID:19682730 | sodium arsenite | increases expression | ISO | RGD:1603405 | 6480464 | sodium arsenite results in increased expression of ICMT mRNA | CTD | PMID:28595984, PMID:34032870 | tamoxifen | affects expression | ISO | RGD:1550037 | 6480464 | Tamoxifen affects the expression of ICMT mRNA | CTD | PMID:17555576 | tert-butyl hydroperoxide | decreases expression | ISO | RGD:1603405 | 6480464 | tert-Butylhydroperoxide results in decreased expression of ICMT mRNA | CTD | PMID:15336504 | valproic acid | multiple interactions | ISO | RGD:1603405 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ICMT mRNA | CTD | PMID:17183730 | valproic acid | increases expression | ISO | RGD:1550037 | 6480464 | Valproic Acid results in increased expression of ICMT mRNA | CTD | PMID:21427059 | valproic acid | increases expression | ISO | RGD:1603405 | 6480464 | Valproic Acid results in increased expression of ICMT mRNA | CTD | PMID:23179753 | valproic acid | increases methylation | ISO | RGD:1603405 | 6480464 | Valproic Acid results in increased methylation of ICMT gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of ICMT mRNA | CTD | PMID:23034163 | |